Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Zealand adds two observers to board of directors

Martin Nicklasson and Catherine Moukheibir join the firm

European Commission forms €2.5bn big data partnership

Says mastering data will lead to better health outcomes

- PMLiVE

SMC fails to recommend Roche’s Perjeta

Says drug is not a cost-effective option in breast cancer

- PMLiVE

Dendreon files for bankruptcy protection

Follows poor sales of cancer vaccine Provenge

- PMLiVE

FDA to review Amgen’s cholesterol drug

US regulator accepts first in new class of PCSK9 inhibitors

Eli Lilly HQ

Lilly launches GLP-1 agonist Trulicity in US

Once-weekly treatment will challenge GSK's Tanzeum, AZ's Bydureon and Novo's Victoza in diabetes

Zealand Pharma appoints new CEO

Britt Meelby Jensen joins from cancer diagnostics firm Dako

- PMLiVE

Integrating digital: developing a social conference

Boehringer Ingelheim’s director of oncology Albert van Eijk on the digital elements of its multichannel efforts

EISAI

Eisai opens first office in Australia

New Melbourne base to support marketing of Halaven and Fycompa

- PMLiVE

Jeffrey Wilks leaves eBay for inVentiv Health

He joins pharma services group as first president of advertising

- PMLiVE

Triple therapy ‘might cure hep C in six weeks’

Phase II trials shows promise for Merck and Gilead drugs

- PMLiVE

Political tensions halt Fresenius’ Russian joint venture

Venture was due to complete by the end of the year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links